Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Characterization of zebrafish von Willebrand factor reveals conservation of domain structure, multimerization, and intracellular storage.

Ghosh A, Vo A, Twiss BK, Kretz CA, Jozwiak MA, Montgomery RR, Shavit JA.

Adv Hematol. 2012;2012:214209. doi: 10.1155/2012/214209. Epub 2012 Sep 24. Erratum in: Adv Hematol. 2015;2015:526854.

2.

Weibel-Palade bodies: a window to von Willebrand disease.

Valentijn KM, Eikenboom J.

J Thromb Haemost. 2013 Apr;11(4):581-92. doi: 10.1111/jth.12160. Review.

4.

Intracellular storage and regulated secretion of von Willebrand factor in quantitative von Willebrand disease.

Wang JW, Valentijn KM, de Boer HC, Dirven RJ, van Zonneveld AJ, Koster AJ, Voorberg J, Reitsma PH, Eikenboom J.

J Biol Chem. 2011 Jul 8;286(27):24180-8. doi: 10.1074/jbc.M110.215194. Epub 2011 May 19.

5.

Analysis of intracellular storage and regulated secretion of 3 von Willebrand disease-causing variants of von Willebrand factor.

Michaux G, Hewlett LJ, Messenger SL, Goodeve AC, Peake IR, Daly ME, Cutler DF.

Blood. 2003 Oct 1;102(7):2452-8. Epub 2003 Jun 5.

6.

Von Willebrand disease and Weibel-Palade bodies.

Wang JW, Eikenboom J.

Hamostaseologie. 2010 Aug;30(3):150-5. Review.

PMID:
20680229
7.

Laboratory diagnosis and molecular classification of von Willebrand disease.

Gadisseur A, Hermans C, Berneman Z, Schroyens W, Deckmyn H, Michiels JJ.

Acta Haematol. 2009;121(2-3):71-84. doi: 10.1159/000214846. Epub 2009 Jun 8. Review.

PMID:
19506352
8.

The mutation N528S in the von Willebrand factor (VWF) propeptide causes defective multimerization and storage of VWF.

Haberichter SL, Budde U, Obser T, Schneppenheim S, Wermes C, Schneppenheim R.

Blood. 2010 Jun 3;115(22):4580-7. doi: 10.1182/blood-2009-09-244327. Epub 2010 Mar 24.

9.

Re-establishment of VWF-dependent Weibel-Palade bodies in VWD endothelial cells.

Haberichter SL, Merricks EP, Fahs SA, Christopherson PA, Nichols TC, Montgomery RR.

Blood. 2005 Jan 1;105(1):145-52. Epub 2004 Aug 26.

10.
11.

Loss of cysteine 584 impairs the storage and release, but not the synthesis of von Willebrand factor.

Daidone V, Barbon G, Pontara E, Cattini GM, Gallinaro L, Zampese E, Pizzo P, Casonato A.

Thromb Haemost. 2014 Dec;112(6):1159-66. doi: 10.1160/TH14-04-0391. Epub 2014 Sep 18.

PMID:
25230768
12.

von Willebrand factor remodeling during exocytosis from vascular endothelial cells.

Mourik MJ, Valentijn JA, Voorberg J, Koster AJ, Valentijn KM, Eikenboom J.

J Thromb Haemost. 2013 Nov;11(11):2009-19. doi: 10.1111/jth.12401.

13.

Storage and secretion of naturally occurring von Willebrand factor A domain variants.

Groeneveld DJ, Wang JW, Mourik MJ, Dirven RJ, Valentijn KM, Voorberg J, Reitsma PH, Eikenboom J.

Br J Haematol. 2014 Nov;167(4):529-40. doi: 10.1111/bjh.13074. Epub 2014 Aug 8.

PMID:
25103891
14.

Homozygous type 2N R854W von Willebrand factor is poorly secreted and causes a severe von Willebrand disease phenotype.

Castaman G, Giacomelli SH, Jacobi P, Obser T, Budde U, Rodeghiero F, Haberichter SL, Schneppenheim R.

J Thromb Haemost. 2010 Sep;8(9):2011-6. doi: 10.1111/j.1538-7836.2010.03971.x.

15.

Reduced von Willebrand factor secretion is associated with loss of Weibel-Palade body formation.

Castaman G, Giacomelli SH, Jacobi PM, Obser T, Budde U, Rodeghiero F, Schneppenheim R, Haberichter SL.

J Thromb Haemost. 2012 May;10(5):951-8. doi: 10.1111/j.1538-7836.2012.04702.x.

16.

Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD).

Budde U, Schneppenheim R, Eikenboom J, Goodeve A, Will K, Drewke E, Castaman G, Rodeghiero F, Federici AB, Batlle J, Pérez A, Meyer D, Mazurier C, Goudemand J, Ingerslev J, Habart D, Vorlova Z, Holmberg L, Lethagen S, Pasi J, Hill F, Peake I.

J Thromb Haemost. 2008 May;6(5):762-71. doi: 10.1111/j.1538-7836.2008.02945.x. Epub 2008 Mar 1.

17.

Zebrafish von Willebrand factor.

Carrillo M, Kim S, Rajpurohit SK, Kulkarni V, Jagadeeswaran P.

Blood Cells Mol Dis. 2010 Dec 15;45(4):326-33. doi: 10.1016/j.bcmd.2010.10.002. Epub 2010 Oct 29.

18.

von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy.

Lillicrap D.

Blood. 2013 Nov 28;122(23):3735-40. doi: 10.1182/blood-2013-06-498303. Epub 2013 Sep 24. Review.

19.

Molecular genetics of von Willebrand disease.

Mazurier C, Ribba AS, Gaucher C, Meyer D.

Ann Genet. 1998;41(1):34-43. Review.

PMID:
9599650
20.

Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets.

Hillery CA, Mancuso DJ, Evan Sadler J, Ponder JW, Jozwiak MA, Christopherson PA, Cox Gill J, Paul Scott J, Montgomery RR.

Blood. 1998 Mar 1;91(5):1572-81.

Supplemental Content

Support Center